Active Ingredient: MARALIXIBAT CHLORIDE
Proprietary Name: LIVMARLI
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: EQ 9.5MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214662
Product Number: 001
Approval Date: Sep 29, 2021
Applicant Holder Full Name: MIRUM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
